SI

Syed Iqbal Haidar Baqrai

Active Director Designated Partner DIN 11408253
DIN 11408253 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Syed Iqbal Haidar Baqrai

Data last updated:

Syed Iqbal Haidar Baqrai is a Designated Partner at Agis Healthcare Llp (since 2025).

DIN 11408253
Primary Designation Designated Partner
First Appointment 04 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 Dec 20252025Active

Board colleagues of Syed Iqbal Haidar Baqrai

NameDINCompanyDesignation
Abdul Gayas11408254Agis Healthcare LlpDesignated Partner
Syed Rizwan Raza11408255Agis Healthcare LlpDesignated Partner
Vibhor Kumar Singh11408256Agis Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Agis Healthcare Llp
Premium access

Shareholding and investment profile for Syed Iqbal Haidar Baqrai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syed Iqbal Haidar Baqrai

Syed Iqbal Haidar Baqrai currently holds 1 directorship: Agis Healthcare Llp (Designated Partner, since 04 Dec 2025).

Syed Iqbal Haidar Baqrai was first appointed on 04 Dec 2025 as Designated Partner at Agis Healthcare Llp.

The current boards of Syed Iqbal Haidar Baqrai's companies include Abdul Gayas (Agis Healthcare Llp), Syed Rizwan Raza (Agis Healthcare Llp), Vibhor Kumar Singh (Agis Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available